CCL2 and Bartsocas-Papas syndrome 1: In this study, BPs treatment resulted in a decrease in renal expression of MCP-1, indicating that the effect of BPs on kidney inflammation might be mediated by reduced MCP-1 expression and macrophage recruitment.